Roger Goldstein, MB, ChB, MRCP (UK), FRCP (UK), FCCP
University of Toronto, Toronto, ON
Session Description
PR is a comprehensive intervention designed to improve physical and mental health and to promote health enhancing behaviours. Although PR is recognized as an essential component of CRD management it remains underutilized. Previous guidelines (2007, 2011) focused primarily on COPD where the bulk of the evidence was. This evidence base has now increased substantially to involve other CRD as well as innovative methods of program delivery.
This presentation will focus on the updated (2023) PR international guidelines. The panel identified 6 relevant clinical questions regarding the application of PR for stable and post AECOPD patients, its use in ILD and PH, its remote delivery through tele-rehabilitation and the role of maintenance programs. Greater knowledge of guidelines for PR should highlight its role in evidence-based healthcare and encourage patient referrals.
Learning Objectives
At the end of this presentation, attendees will be able to:
- Identify the six questions addressed in the updated 2023 PR guidelines
- Distinguish recommendations from systematic reviews of randomized controlled trials from implementation issues, values and preferences
- Choose the most important clinical research questions for the future
CanMEDS Roles: Collaborator, Communicator, Health Advocate, Leader, Medical Expert, Professional, Scholar
